Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness study

Authors: Flamm, Jason A | Journal Of The International Aids Society | September 1, 2022 | PubMed abstract

Explore all publications

Back To Top